Synapse - Works

Results (5598)

Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status

Meeting Abstract

Ricciuti, B.; Arbour, K. C.; Lin, J. J.; Vokes, N.; Hoojghan, A. V.; Li, Y. Y.; Cherniack, A. D.; Recondo, G.; Lamberti, G.; Venkatraman, D.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Error-free, automated data integration of exosome cargo protein data with extensive clinical data in an ongoing, multi-omic translational research study

Meeting Abstract

Oromendia, A.; Ismailgeci, D.; Ciofii, M.; Donnelly, T.; Bojmar, L.; Jyazbek, J.; Chatterjee, A.; Lyden, D.; Yu, K. H.; Kelsen, D. P.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

A phase III trial of docetaxel versus docetaxel and radium-223 (Ra-223) in patients with metastatic castration-resistant prostate cancer (mCRPC): DORA

Meeting Abstract

Morris, M. J.; De Wit, R.; Vogelzang, N. J.; Tagawa, S. T.; Higano, C. S.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Phase I study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting DLL3, in patients with small cell lung cancer (SCLC)

Meeting Abstract

Owonikoko, T. K.; Borghaei, H.; Champiat, S.; Paz-Ares, L. G.; Govindan, R.; Boyer, M. J.; Johnson, M. L.; Udagawa, H.; Hummel, H. D.; Salgia, R.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Technology-enabled longitudinal monitoring of patient-reported outcomes (PROs) to individualize care of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ICIs)

Meeting Abstract

Msaouel, P.; Van Alstine, M. L.; Oromendia, C.; Gao, J.; Wang, Y.; Siddiqui, B. A.; Siefker-Radtke, A. O.; Shah, A. Y.; Shaw, L.; Lopez, L.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Automated identification of lymphoma involving the bone from PET/CT reports using natural language processing and adaptive learning

Meeting Abstract

Navitski, A.; Goyal, P.; Ahsanuddin, S.; Zheng, S.; Joffe, E.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Locoregional control, failure patterns and clinical outcomes in patients with stage III non-small cell lung cancers treated with chemoradiation and durvalumab

Meeting Abstract

Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A.; Simone, C. B.; Gelblum, D. Y.; Wu, A. J. C.; Lee, N. Y.; Kris, M. G.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

INDIGO: A global, randomized, double-blind, phase III study of vorasidenib (VOR; AG-881) vs placebo in patients (pts) with residual or recurrent grade II glioma with an isocitrate dehydrogenase 1/2 (IDH1/2) mutation

Meeting Abstract

Mellinghoff, I. K.; Van den Bent, M. J.; Clarke, J. L.; Maher, E. A.; Peters, K. B.; Touat, M.; De Groot, J. F.; De La Fuente, M. I.; Arrillaga-Romany, I.; Wick, W.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Superior therapy response predictions for patients with pancreatic cancer (PDAC) using Cellworks Singula: MyCare-009-05

Meeting Abstract

Moffat, G. T.; Watson, D.; Kapoor, S.; Roy, K. G. G.; Parashar, R.; Alam, A.; Alam, A.; Tyagi, A.; Singh, D.; Kumari, P.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Enhancement of the therapeutic effects of oncolytic vaccinia virus by using autologous and allogeneic cell-based delivery platforms

Meeting Abstract

Minev, B.; Santidrian, A. F.; Minev, I.; Nguyen, D.; Zamarin, D.; Marincola, F.; Draganov, D. D.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save